
Hey Doc, let’s talk biotech stocks. Are you chasing quick profits with short-term trades, or are you playing the long game, holding for years of growth? If you’re leaning toward trading, stick with me—this one’s for you. After 15 years in the life sciences trenches, I’ve learned one truth: biotech investing isn’t about flashy, fast trades. It’s about patience—and that patience can build serious wealth.
Biotech stocks are a wild ride. Even the best companies, with game-changing drugs or platforms, can see their stock plummet on market whims. You buy in, convinced the stock’s about to soar, only to watch it tank 20% overnight. Frustrating, right? If you’re trading for short-term gains, that dip might send you running for the exit. But here’s the secret: those dips are often noise, not signals. The real money in biotech comes from researching a company’s fundamentals, buying in, and holding on for the long haul.
Let me paint you a picture with a real-world example—Mystery Stock A (ticker: MSA, for compliance reasons). This company’s a gem in cancer diagnostics, with tests that screen for deadly cancers like stomach and pancreatic. As a physician, you know the demand for these tests is skyrocketing. MSA’s tech isn’t just promising; it’s already delivering.
When I dug into MSA’s fundamentals, the opportunity was clear. Spun off from a major pharma that acquired it for-squared for $8 billion, MSA hit the public market at a mere $400 million valuation. That’s a steal for a company with proven diagnostics and strong capital backing (the parent company’s reputation is on the line, after all). But after I bought in, the stock took a 20% dive and languished for months. Sound like a trader’s nightmare? Maybe. But for a long-term investor, it was a chance to double down.
Why? Because MSA’s fundamentals were rock-solid. Sales were climbing, and they inked partnerships with major diagnostic firms to scale their tests. I didn’t sell—I bought more. My total investment for our biotech hedge fund (Evergrowth)? $126,000 at an average price of $25.36 per share. Fast forward to today, and we’re sitting on a 51.4% unrealized gain—$64,589— for MSA and I haven’t sold a single share. Why? I believe MSA’s intrinsic value is closer to that $8 billion acquisition price. That’s the kind of upside you miss if you’re trading for quick bucks.
The lesson? Short-term trading in biotech is a trap. That 20% dip in MSA would’ve crushed a trader’s spirit. But with a long-term mindset, you see past the noise. You focus on the company’s true worth—its drugs, its platform, its growth potential—and let time work its magic.
Next time you’re tempted to fire up those fancy technical charts for a biotech trade, pause. Think fundamentals. Think years, not weeks. Patience isn’t just a virtue in biotech investing—it’s a superpower. Let it grow your wealth irresistibly over time.
Enjoyed This? Stick Around! Follow me and subscribe to my newsletter for more insights on using your MD advantage in biotech investing.
You pour countless hours into your clinic or hospital, saving lives but often sacrificing your own—your health, your family, your freedom. You’re trading precious time for dollars, with little left for travel or the life you want.
Allow me to ask you the following questions:
- Would more time and money let you live better?
- What if you could change that?
- What if you leveraged your medical expertise to make your hard-earned dollars grow through smart investing?
- Would working smarter, not harder, transform your life?
- How about having a voice in investments that grow your wealth and help your patients?
If any of these hit home, our biotech hedge fund (Evergrowth BioHealthcare Capital)—designed by doctors, for doctors—might be your answer. Here’s what you’d gain by joining us:
- Invest in what you know, using your clinical edge.
- Grow your wealth into generational riches for you and your kids.
- Work fewer hours as your investments take off.
- Retire early to travel and live more.
- Prioritize your health and happiness.
- Connect with other physician investors.
- Support innovations that bring hope to patients on a massive scale.
- Become a Medical Advisor (just one hour a month commitment).
- We only get a small share of your profits, if and only if, we can beat the 8% average stock market performance for you.
Check out our Fund Presentation at https://evergrowthinvest.com/presentation/.
Join our Skool community page at https://www.skool.com/evergrowthbiohealthcarecapital
Schedule a free consultation with me to see if we are the right fit https://calendly.com/drharveytran/evergrowth-introduction?month=2025-05.
Disclaimer: This blog is for educational and informational purposes only. It’s not a recommendation to buy, sell, or hold any stock. Always consult your investment advisor and do your due diligence before investing. In working smarter rather than harder, I wrote an initial draft based on my knowledge, experience, and insight. I then leverage AI to put the information together into this presentable format.
More Reads for You:
- Doc, Unleash Your Biotech Investing Edge with PDUFA Knowledge! https://www.linkedin.com/pulse/doc-unleash-your-biotech-investing-edge-pdufa-harvey-tran-m-d-m-s–o6oae/
- Investing for Physicians: The Power of Diversification https://www.linkedin.com/pulse/investing-physicians-power-diversification-harvey-tran-m-d-m-s–j5hse/
- Biotech Investing For Physicians: Why Popular Stocks Could Leave You Holding the Bag https://www.linkedin.com/pulse/biotech-investing-physicians-why-popular-stocks-could-harvey-mxpke/
- Doctors, Are You Trading Hours for Dollars or Building Generational Wealth?https://www.linkedin.com/pulse/doctors-you-trading-hours-dollars-building-wealth-tran-m-d-m-s–466we/
- Biotech Investing: Use Your Medical Expertise to Slash Risks and Boost Returns https://www.linkedin.com/pulse/biotech-investing-use-your-medical-expertise-slash-tran-m-d-m-s–ry4fe/?trackingId=7uIZKG2SRoSWc2tkc3gIzQ%3D%3D
- Doctors, Your Clinical Edge Is Your Investing Superpower: My Telemedicine Win https://www.linkedin.com/pulse/doctors-your-clinical-edge-investing-superpower-my-tran-m-d-m-s–6ivge/
- Your MD Investing Advantage: Why a Biotech’s Sales Partner Is Your Key to Blockbuster Returns https://www.linkedin.com/pulse/your-md-investing-advantage-why-biotechs-sales-key-tran-m-d-m-s–pw1ae/
- Your MD Advantage: Why Antibiotic Stocks Like Melinta Crash and Burn https://www.linkedin.com/pulse/your-md-advantage-why-antibiotic-stocks-like-melinta-harvey-vsqee/
- Why Physicians Are Primed to Spot Biotech Winners: A Potentially Game-Changing Alzheimer’s Test https://www.linkedin.com/pulse/why-physicians-primed-spot-biotech-winners-alzheimers-harvey-csfte/
- Why Physicians and Healthcare Providers Make Great Biotech Investors? https://www.linkedin.com/pulse/why-physicians-healthcare-providers-make-great-tran-m-d-m-s–the0e/
- Don’t Let a Losing Stock Stop You—Here’s Why You Should Keep Investing https://www.linkedin.com/pulse/dont-let-losing-stock-stop-youheres-why-you-should-tran-m-d-m-s–nnxye/